Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8801
Quantum Computing Inc
QUBT
$2.07B
| $22.9K | ﹤0.01% |
+25,109
| New | +$21.6K |
|
|
PFIE
8802
DELISTED
Profire Energy, Inc
PFIE
| $22.8K | ﹤0.01% |
12,612
-90,071
| -88% | -$169K |
|
8803
CALL
Dragonfly Energy
DFLI
$18.9M
| $22.8K | ﹤0.01% |
468
-1,362
| -74% | -$103K |
|
8804
Inno Holdings
INHD
$23.2M
| $22.7K | ﹤0.01% |
+3
| New | +$38.9K |
|
|
UHGWW
8805
DELISTED
United Homes Group Warrant
UHGWW
| $22.6K | ﹤0.01% |
23,377
-387
| -2% | -$317 |
|
|
CARV
8806
DELISTED
Carver Bancorp
CARV
| $22.3K | ﹤0.01% |
+11,326
| New | +$19.5K |
|
|
OTLY
8807
PUT
Oatly Group
OTLY
$438M
| $22.1K | ﹤0.01% |
885
-465
| -34% | -$7.67K |
|
|
ORGN
8808
CALL
DELISTED
Origin Materials
ORGN
| $21.6K | ﹤0.01% |
860
-33
| -4% | -$946 |
|
8809
MediciNova
MNOV
$66M
| $21.5K | ﹤0.01% |
+14,345
| New | +$25.9K |
|
8810
Orion Energy Systems
OESX
$80.6M
| $21.3K | ﹤0.01% |
+2,460
| New | +$24.2K |
|
|
MLGO
8811
MicroAlgo
MLGO
$45.6M
| $21.2K | ﹤0.01% |
+4
| New | +$71.2K |
|
8812
Outlook Therapeutics
OTLK
$191M
| $20.8K | ﹤0.01% |
+2,644
| New | +$22.4K |
|
8813
Humacyte Inc Warrant
HUMAW
$1.24M
| $20.8K | ﹤0.01% |
50,000
| – | – |
|
8814
CALL
Taysha Gene Therapies
TSHA
$1.89B
| $20.5K | ﹤0.01% |
11,600
-24,700
| -68% | -$49.2K |
|
8815
Theriva Biologics
TOVX
$10.1M
| $20.5K | ﹤0.01% |
1,902
+1,209
| +174% | +$14.9K |
|
|
RBT
8816
DELISTED
Rubicon Technologies, Inc.
RBT
| $20.4K | ﹤0.01% |
+11,052
| New | +$21.7K |
|
8817
TriSalus Life Sciences Warrant
TLSIW
$40.7M
| $20.4K | ﹤0.01% |
17,174
-85
| -0.5% | -$38 |
|
8818
MiNK Therapeutics
INKT
$54.6M
| $19.7K | ﹤0.01% |
+1,839
| New | +$19.2K |
|
8819
PUT
Clover Health Investments
CLOV
$2.51B
| $19.6K | ﹤0.01% |
20,600
+6,100
| +42% | +$5.99K |
|
|
NOTE.WS
8820
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
| $19.5K | ﹤0.01% |
62,500
-2,343
| -4% | -$798 |
|
|
AKTS
8821
DELISTED
Akoustis Technologies Inc
AKTS
| $19.5K | ﹤0.01% |
23,378
-88,109
| -79% | -$59.2K |
|
|
OGI
8822
Organigram Holdings
OGI
$139M
| $19.4K | ﹤0.01% |
14,949
-1,145
| -7% | -$1.41K |
|
|
LICY
8823
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
| $19.2K | ﹤0.01% |
4,113
-450
| -10% | -$5.11K |
|
8824
PUT
Rigetti Computing
RGTI
$5.99B
| $19.1K | ﹤0.01% |
19,400
-6,200
| -24% | -$7.07K |
|
8825
Pluri
PLUR
$19.6M
| $19.1K | ﹤0.01% |
4,115
-1,141
| -22% | -$5.09K |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.